Literature DB >> 6145775

Competitive antagonism of alpha 1-adrenoceptor mediated pressor responses in the rat mesenteric artery.

G A McPherson, I M Coupar, D A Taylor.   

Abstract

(-)-Noradrenaline-mediated pressor responses in the rat mesenteric artery preparation are blocked by alpha 1-adrenoceptor antagonists, BE2254 and prazosin with pA2 values of 8.59 and 8.52 respectively. The alpha 2-adrenoceptor selective antagonist rauwolscine, does not influence responses to (-)-noradrenaline in concentrations up to 10 microM. This rank order is consistent with an alpha 1-adrenoceptor mediated effect. Shifts in the (-)-noradrenaline dose-response curve produced by BE2254 and prazosin were parallel and there was no significant effect on the observed maximal response. Slope values from Schild plots were not significantly different from unity indicating that these antagonists were behaving as classical competitive antagonists.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6145775     DOI: 10.1111/j.2042-7158.1984.tb04389.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  4 in total

1.  Analysis of the effects of alpha 1-adrenoceptor antagonists on noradrenaline-mediated contraction of rat small mesenteric artery.

Authors:  P H Van der Graaf; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

2.  In vivo and in vitro activity of selective 5-hydroxytryptamine2 receptor antagonists.

Authors:  S Conolan; M J Quinn; D A Taylor
Journal:  Br J Pharmacol       Date:  1986-09       Impact factor: 8.739

3.  Phentolamine and structurally related compounds selectively antagonize the vascular actions of the K+ channel opener, cromromakalim.

Authors:  G A McPherson; J A Angus
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

4.  Effect of chlorpromazine on sympathetic neuroeffector transmission in the rabbit isolated pulmonary artery and aorta.

Authors:  O A Nedergaard; J Abrahamsen
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.